Suppr超能文献

采用规律的出汗活动治疗伴有或不伴有获得性特发性全身性无汗症的胆碱能性荨麻疹。

Regular sweating activities for the treatment of cholinergic urticaria with or without acquired idiopathic generalized anhidrosis.

作者信息

Minowa Tomoyuki, Sumikawa Yasuyuki, Kan Yuji, Kamiya Takafumi, Uhara Hisashi

机构信息

Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.

出版信息

Dermatol Ther. 2020 Jul;33(4):e13647. doi: 10.1111/dth.13647. Epub 2020 Jun 7.

Abstract

Cholinergic urticaria (CholU) decreases affected individuals' quality of life because they must avoid stimuli including exercise and hot bathing. Although case reports have indicated that regular sweating activities are effective for CholU with hypohidrosis, little evidence is available. This retrospective medical record review examined CholU patients who received any form of treatment at our hospital. Twenty-seven cases (78% men; median age 22 years, range 12-70 years) were analyzed. Fourteen (52%) patients had acquired idiopathic generalized anhidrosis (AIGA). Among the 12 patients receiving sweating therapy (4 with, 8 without AIGA), improvement of symptoms was confirmed in 11 (92%; sweating therapy alone: n = 5, with H1 blocker: n = 5, with steroid pulse: n = 1) including 8 (67%) showing complete response (CR). In this sweating-therapy group, CR was achieved by six of the eight (75%) patients without AIGA and two of the four (50%) patients with AIGA. Among the 15 patients without sweating therapy, symptom improvement was observed in 9 (60%; steroid pulse: n = 7, H1 blocker: n = 2) including 1 (7%) achieving CR. Sweating therapy was safely undertaken except in one case in which the patient showed angioedema and anaphylaxis. Regular sweating activities could be a potential therapeutic option for CholU patients.

摘要

胆碱能性荨麻疹(CholU)会降低患者的生活质量,因为患者必须避免包括运动和热水浴在内的刺激因素。尽管病例报告表明,规律的出汗活动对伴有少汗症的胆碱能性荨麻疹有效,但相关证据较少。本回顾性病历审查研究了在我院接受过任何形式治疗的胆碱能性荨麻疹患者。分析了27例患者(78%为男性;中位年龄22岁,范围12 - 70岁)。14例(52%)患者患有获得性特发性全身无汗症(AIGA)。在接受出汗疗法的12例患者中(4例伴有AIGA,8例不伴有AIGA),11例(92%;单纯出汗疗法:n = 5,联合H1阻滞剂:n = 5,联合类固醇冲击疗法:n = 1)症状得到改善,其中8例(67%)表现为完全缓解(CR)。在这个出汗疗法组中,8例不伴有AIGA的患者中有6例(75%)以及4例伴有AIGA的患者中有2例(50%)实现了CR。在未接受出汗疗法的15例患者中,9例(60%;类固醇冲击疗法:n = 7,H1阻滞剂:n = 2)症状有所改善,其中1例(7%)实现了CR。除1例患者出现血管性水肿和过敏反应外,出汗疗法实施过程安全。规律的出汗活动可能是胆碱能性荨麻疹患者的一种潜在治疗选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验